NYSE:APUS | Operating Income | Apimeds Pharmaceuticals US, Inc.

Complete source-backed operating income history.

Available history
2023-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$6.28M
2026-03-31-$12.19M
2025-12-31-$7.04M
2025-09-30-$1.84M
2025-06-30-$2.66M
2025-03-31-$364,368.00
2024-12-31-$275,613.00
2024-09-30-$299,999.00
2024-06-30-$427,757.00
2024-03-31-$271,726.00

Annual Operating Income

DateOperating Income
2025-12-31-$11.91M
2024-12-31-$1.28M
2023-12-31-$747,436.00